Objective: Single inhaler triple therapy is widely used in Chronic Obstructive Pulmonary Disease (COPD) and asthma. This research aimed to analyze adverse events (AEs ...

Trimbow (beclometasone+formoterol+glycopyrronium) combines an inhaled corticosteroid (ICS), a long-acting beta adrenoceptor agonist (LABA) and a long-acting muscarinic antagonist (LAMA ...

PT010 is based on the inhaled corticosteroid budesonide, long-acting muscarinic antagonist (LAMA) glycopyrronium and long-acting beta agonist (LABA) formoterol fumarate, and has been filed for ...

a Department of Paediatrics, Kolding Hospital, DK-6000 Kolding, Denmark, b Astra Draco AB, PO Box 34, S-221 00, Lund, Sweden AIM To evaluate the systemic availability and basic pharmacokinetic ...

Associate Health Minister with responsibility for Pharmac David Seymour is pleased to see Pharmac continue to increase availability of medicines for Kiwis with the government’s largest ever investment ...

Pharmac’s achievements as historic funding enable access to new, life-saving medicines for New Zealanders, Associate Health Minister David Seymour said. Pharmac, New Zealand's medicine ...

7 Department of Rheumatology, Birmingham Heartlands and Solihull Hospital NHS Trust, Birmingham, UK 8 Department of Rheumatology, Weston General Hospital, Weston Super Mare, Avon, UK 9 Department of ...

Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is a commonly encountered yet loosely defined clinical entity. ACOS accounts for approximately 15–25% of the ...

The systemic effects seen over eight hours after inhalation of three doses of salmeterol and formoterol were therefore compared in normal subjects. RESULTS Both salmeterol and formoterol caused an ...

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...